LGALS1 and systemic sclerosis: To further investigate the association of serum Gal-1 and Gal-3 with clinical manifestations of SSc, patients were classified into 2 groups according to the presence or absence of organ involvement, and galectin concentrations were assessed in these two groups (Table 2).